首页 > 市场调查报告书 > 製药

再生医学细胞疗法

市场调查报告书

商品编码

1390475

自然杀手细胞治疗市场：2023-2028 年全球产业趋势、份额、规模、成长、机会与预测

Natural Killer Cells Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日期: 2023年11月24日 | 出版商:

IMARC | 英文 138 Pages | 商品交期: 2-3个工作天内

价格

简介目录图表

抽象的

2022年，全球自然杀手细胞治疗市场规模达到25亿美元。展望未来， IMARC Group预计到2028年市场规模将达到54亿美元，2022-2028年复合年增长率（CAGR）为13.70%。

自然杀手 (NK) 细胞疗法针对多种致病抗原，具有高效的细胞毒性，并降低细胞激素风暴的风险。它们可以从多种来源生产，而不依赖患者特异性免疫细胞。目前，已经开发了多种策略，例如用细胞激素或小分子药物进行体外预处理以及设计嵌合抗原受体（CAR）NK，从而提高NK细胞治疗的功效。此外，研究人员正致力于透过强大的扩增、增强的靶向性和延长强效免疫细胞的持久性来最大化同种异体 NK 细胞的治疗效果。这也有助于释放强大而持续的抗癌免疫介导攻击。

自然杀手细胞治疗市场趋势：

患有癌症、传染病和肝臟疾病的人数显着增加是推动市场成长的主要因素之一。这可归因于不健康的饮食模式、缺乏体力活动、日益严重的空气污染以及越来越多的人消费酒精和烟草产品。此外，随着年龄的增长，罹患癌症的风险急剧上升，全球不断增加的老年人口正在成为另一个生长诱导因素，催化对 NK 细胞疗法的需求。除此之外，由于癌症患者的免疫反应不足，医疗公司正在开发新的方法和技术，透过同种异体、现成的 NK 细胞疗法来增强免疫反应。此外，专注于肿瘤靶向抗体策略的临床研究数量增加，以增强基于 NK 细胞的疗法的治疗效果，同时最大限度地降低风险和毒性。此外，许多国家的管理机构正在为癌症患者的财务计划提供资金，这为市场创造了良好的前景。

本报告回答的关键问题

2022 年全球自然杀手细胞治疗市场规模有多大？
2023-2028年全球自然杀手细胞治疗市场的预期成长率是多少？
推动全球自然杀手细胞治疗市场的关键因素是什么？
COVID-19 对全球自然杀手细胞治疗市场有何影响？
基于疗法的全球自然杀手细胞疗法市场的细分是什么？
基于应用的全球自然杀手细胞治疗市场的细分情况如何？
基于最终用户的全球自然杀手细胞治疗市场的细分情况如何？
全球自然杀手细胞治疗市场的关键区域有哪些？
谁是全球自然杀手细胞治疗市场的主要参与者/公司？

北美洲
- 美国
  - 市场走向
  - 市场预测
- 加拿大
  - 市场走向
  - 市场预测
亚太
- 中国
  - 市场走向
  - 市场预测
- 日本
  - 市场走向
  - 市场预测
- 印度
  - 市场走向
  - 市场预测
- 韩国
  - 市场走向
  - 市场预测
- 澳洲
  - 市场走向
  - 市场预测
- 印尼
  - 市场走向
  - 市场预测
- 其他的
  - 市场走向
  - 市场预测
欧洲
- 德国
  - 市场走向
  - 市场预测
- 法国
  - 市场走向
  - 市场预测
- 英国
  - 市场走向
  - 市场预测
- 义大利
  - 市场走向
  - 市场预测
- 西班牙
  - 市场走向
  - 市场预测
- 俄罗斯
  - 市场走向
  - 市场预测
- 其他的
  - 市场走向
  - 市场预测
拉丁美洲
- 巴西
  - 市场走向
  - 市场预测
- 墨西哥
  - 市场走向
  - 市场预测
- 其他的
  - 市场走向
  - 市场预测
中东和非洲
- 市场走向
- 按国家/地区分類的市场细分
- 市场预测

第 10 章：SWOT 分析

概述
优势
弱点
机会
威胁

第 11 章：价值链分析

第 12 章：波特五力分析

概述
买家的议价能力
供应商的议价能力
竞争程度
新进入者的威胁
替代品的威胁

第 13 章：价格分析

第14章：竞争格局

市场结构
关键参与者
关键参与者简介
- Affimed GmbH
- Bristol-Myers Squibb Company
- Fate Therapeutics
- Fortress Biotech Inc.
- Glycostem Therapeutics
- Innate Pharma SA
- Kuur Therapeutics Inc. (Athenex Inc.)
- Nkarta Inc.
- Takeda Pharmaceutical Company Limited
- Ziopharm Oncology Inc.

简介目录图表

Product Code: SR112023A4214

Abstract

The global natural killer cells therapeutics market size reached US$ 2.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 5.4 Billion by 2028, exhibiting a growth rate (CAGR) of 13.70% during 2022-2028.

Natural killer (NK) cells therapeutics target multiple pathogenic antigens with efficient cytotoxicity and reduce the risk of cytokine storms. They can be produced from a variety of sources without relying on patient-specific immune cells. At present, several strategies have been developed, such as ex vivo pre-conditioning with cytokines or small molecular drugs and engineering a chimeric antigen receptor (CAR) NK, which improve the efficacy of NK cells therapeutics. Moreover, researchers are focusing on maximizing the therapeutic effects of allogeneic NK cells through robust expansion, enhanced targeting, and extended persistence of potent immune cells. This can also help unleash a strong and sustained anti-cancer immune-mediated attack.

Natural Killer Cells Therapeutics Market Trends:

A significant rise in the number of individuals with cancer, infectious diseases, and liver disorders represents one of the primary factors fueling the market growth. This can be attributed to unhealthy dietary patterns, lack of physical activities, growing air pollution, and the increasing number of individuals consuming alcohol and tobacco products. Moreover, as the risk of developing cancer rises dramatically with age, the increasing geriatric population across the globe is acting as another growth-inducing factor catalyzing the demand for NK cells therapeutics. Apart from this, as the immune response of cancer patients is not adequate, health companies are developing novel methods and technologies to boost the immune response through allogeneic, off-the-shelf NK cell-based therapies. Furthermore, there is a rise in the number of clinical studies that focus on tumor-targeted antibody strategies to enhance the therapeutic benefit of NK-cell-based therapy while minimizing risks and toxicities. In addition, governing agencies of numerous countries are funding financial schemes for cancer patients, which is creating a favorable outlook for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global natural killer cells therapeutics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on therapeutics, application and end user.

Breakup by Therapeutics:

NK Cell Therapies

NK Cell Directed Antibodies

Breakup by Application:

Cancer

Gastrointestinal Diseases

Immunoproliferative Disorders

Others

Breakup by End User:

Hospitals

Research Centers and Institutes

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Affimed GmbH, Bristol-Myers Squibb Company, Fate Therapeutics, Fortress Biotech Inc., Glycostem Therapeutics, Innate Pharma S.A., Kuur Therapeutics Inc. (Athenex Inc.), Nkarta Inc., Takeda Pharmaceutical Company Limited and Ziopharm Oncology Inc.

Key Questions Answered in This Report

1. What was the size of the global natural killer cells therapeutics market in 2022?
2. What is the expected growth rate of the global natural killer cells therapeutics market during 2023-2028?
3. What are the key factors driving the global natural killer cells therapeutics market?
4. What has been the impact of COVID-19 on the global natural killer cells therapeutics market?
5. What is the breakup of the global natural killer cells therapeutics market based on the therapeutics?
6. What is the breakup of the global natural killer cells therapeutics market based on the application?
7. What is the breakup of the global natural killer cells therapeutics market based on the end user?
8. What are the key regions in the global natural killer cells therapeutics market?
9. Who are the key players/companies in the global natural killer cells therapeutics market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Natural Killer Cells Therapeutics Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Therapeutics

6.1 NK Cell Therapies
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 NK Cell Directed Antibodies
- 6.2.1 Market Trends
- 6.2.2 Market Forecast

7 Market Breakup by Application

7.1 Cancer
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Gastrointestinal Diseases
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Immunoproliferative Disorders
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Others
- 7.4.1 Market Trends
- 7.4.2 Market Forecast

8 Market Breakup by End User

8.1 Hospitals
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Research Centers and Institutes
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Others
- 8.3.1 Market Trends
- 8.3.2 Market Forecast

9 Market Breakup by Region

9.1 North America
- 9.1.1 United States
  - 9.1.1.1 Market Trends
  - 9.1.1.2 Market Forecast
- 9.1.2 Canada
  - 9.1.2.1 Market Trends
  - 9.1.2.2 Market Forecast
9.2 Asia-Pacific
- 9.2.1 China
  - 9.2.1.1 Market Trends
  - 9.2.1.2 Market Forecast
- 9.2.2 Japan
  - 9.2.2.1 Market Trends
  - 9.2.2.2 Market Forecast
- 9.2.3 India
  - 9.2.3.1 Market Trends
  - 9.2.3.2 Market Forecast
- 9.2.4 South Korea
  - 9.2.4.1 Market Trends
  - 9.2.4.2 Market Forecast
- 9.2.5 Australia
  - 9.2.5.1 Market Trends
  - 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
  - 9.2.6.1 Market Trends
  - 9.2.6.2 Market Forecast
- 9.2.7 Others
  - 9.2.7.1 Market Trends
  - 9.2.7.2 Market Forecast
9.3 Europe
- 9.3.1 Germany
  - 9.3.1.1 Market Trends
  - 9.3.1.2 Market Forecast
- 9.3.2 France
  - 9.3.2.1 Market Trends
  - 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
  - 9.3.3.1 Market Trends
  - 9.3.3.2 Market Forecast
- 9.3.4 Italy
  - 9.3.4.1 Market Trends
  - 9.3.4.2 Market Forecast
- 9.3.5 Spain
  - 9.3.5.1 Market Trends
  - 9.3.5.2 Market Forecast
- 9.3.6 Russia
  - 9.3.6.1 Market Trends
  - 9.3.6.2 Market Forecast
- 9.3.7 Others
  - 9.3.7.1 Market Trends
  - 9.3.7.2 Market Forecast
9.4 Latin America
- 9.4.1 Brazil
  - 9.4.1.1 Market Trends
  - 9.4.1.2 Market Forecast
- 9.4.2 Mexico
  - 9.4.2.1 Market Trends
  - 9.4.2.2 Market Forecast
- 9.4.3 Others
  - 9.4.3.1 Market Trends
  - 9.4.3.2 Market Forecast
9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast

10 SWOT Analysis

10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
- 14.3.1 Affimed GmbH
  - 14.3.1.1 Company Overview
  - 14.3.1.2 Product Portfolio
  - 14.3.1.3 Financials
- 14.3.2 Bristol-Myers Squibb Company
  - 14.3.2.1 Company Overview
  - 14.3.2.2 Product Portfolio
  - 14.3.2.3 Financials
  - 14.3.2.4 SWOT Analysis
- 14.3.3 Fate Therapeutics
  - 14.3.3.1 Company Overview
  - 14.3.3.2 Product Portfolio
  - 14.3.3.3 Financials
- 14.3.4 Fortress Biotech Inc.
  - 14.3.4.1 Company Overview
  - 14.3.4.2 Product Portfolio
  - 14.3.4.3 Financials
- 14.3.5 Glycostem Therapeutics
  - 14.3.5.1 Company Overview
  - 14.3.5.2 Product Portfolio
- 14.3.6 Innate Pharma S.A.
  - 14.3.6.1 Company Overview
  - 14.3.6.2 Product Portfolio
  - 14.3.6.3 Financials
- 14.3.7 Kuur Therapeutics Inc. (Athenex Inc.)
  - 14.3.7.1 Company Overview
  - 14.3.7.2 Product Portfolio
- 14.3.8 Nkarta Inc.
  - 14.3.8.1 Company Overview
  - 14.3.8.2 Product Portfolio
  - 14.3.8.3 Financials
- 14.3.9 Takeda Pharmaceutical Company Limited
  - 14.3.9.1 Company Overview
  - 14.3.9.2 Product Portfolio
  - 14.3.9.3 Financials
  - 14.3.9.4 SWOT Analysis
- 14.3.10 Ziopharm Oncology Inc.
  - 14.3.10.1 Company Overview
  - 14.3.10.2 Product Portfolio
  - 14.3.10.3 Financials

简介目录图表

List of Figures

Figure 1: Global: Natural Killer Cells Therapeutics Market: Major Drivers and Challenges
Figure 2: Global: Natural Killer Cells Therapeutics Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Natural Killer Cells Therapeutics Market: Breakup by Therapeutics (in %), 2022
Figure 5: Global: Natural Killer Cells Therapeutics Market: Breakup by Application (in %), 2022
Figure 6: Global: Natural Killer Cells Therapeutics Market: Breakup by End User (in %), 2022
Figure 7: Global: Natural Killer Cells Therapeutics Market: Breakup by Region (in %), 2022
Figure 8: Global: Natural Killer Cells Therapeutics (NK Cell Therapies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Natural Killer Cells Therapeutics (NK Cell Therapies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Natural Killer Cells Therapeutics (NK Cell Directed Antibodies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Natural Killer Cells Therapeutics (NK Cell Directed Antibodies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Natural Killer Cells Therapeutics (Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Natural Killer Cells Therapeutics (Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Natural Killer Cells Therapeutics (Gastrointestinal Diseases) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Natural Killer Cells Therapeutics (Gastrointestinal Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Natural Killer Cells Therapeutics (Immunoproliferative Disorders) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Natural Killer Cells Therapeutics (Immunoproliferative Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Natural Killer Cells Therapeutics (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Natural Killer Cells Therapeutics (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Natural Killer Cells Therapeutics (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Natural Killer Cells Therapeutics (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Natural Killer Cells Therapeutics (Research Centers and Institutes ) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Natural Killer Cells Therapeutics (Research Centers and Institutes ) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Natural Killer Cells Therapeutics (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Natural Killer Cells Therapeutics (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: North America: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: North America: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: United States: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: United States: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: Canada: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: Canada: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Asia-Pacific: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Asia-Pacific: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: China: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: China: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Japan: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Japan: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: India: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: India: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: South Korea: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: South Korea: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: Australia: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: Australia: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Indonesia: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Indonesia: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Others: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Others: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Europe: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Europe: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Germany: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Germany: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: France: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: France: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: United Kingdom: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: United Kingdom: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: Italy: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: Italy: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: Spain: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: Spain: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Russia: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Russia: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Others: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Others: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Latin America: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Latin America: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Brazil: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Brazil: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Mexico: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Mexico: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Others: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Others: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Middle East and Africa: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Middle East and Africa: Natural Killer Cells Therapeutics Market: Breakup by Country (in %), 2022
Figure 74: Middle East and Africa: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Global: Natural Killer Cells Therapeutics Industry: SWOT Analysis
Figure 76: Global: Natural Killer Cells Therapeutics Industry: Value Chain Analysis
Figure 77: Global: Natural Killer Cells Therapeutics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Natural Killer Cells Therapeutics Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Natural Killer Cells Therapeutics Market Forecast: Breakup by Therapeutics (in Million US$), 2023-2028
Table 3: Global: Natural Killer Cells Therapeutics Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 4: Global: Natural Killer Cells Therapeutics Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 5: Global: Natural Killer Cells Therapeutics Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Natural Killer Cells Therapeutics Market: Competitive Structure
Table 7: Global: Natural Killer Cells Therapeutics Market: Key Players

02-2729-4219

+886-2-2729-4219